Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays

Toxicological Sciences

Volumn 104, Issue 1, 2008, Pages 155-162

  Lison, Dominique ^a   Thomassen, Leen C J ^b   Rabolli, Virginie ^a   Gonzalez, Laetitia ^c   Napierska, Dorota ^b   Seo, Jin Won ^b   Kirsch Volders, Micheline ^c   Hoet, Peter ^b   Kirschhock, Christine E A ^b   Martens, Johan A ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cytotoxicity; Monodisperse silica; Nanoparticles; Nanotoxicology

Indexed keywords

CRYSTAL VIOLET; LACTATE DEHYDROGENASE; NANOPARTICLE; SILICON; SILICON DIOXIDE;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL COUNT; CELL SUSPENSION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DISPERSION; DOSIMETRY; ENDOTHELIUM CELL; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NANOTOXICOLOGY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN;

EID: 45549083261     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn072     Document Type: Article

References (27)

1. Balshaw, D. M., Philbert, M., and Suk, W. A. (2005). Research strategies for safety evaluation of nanomaterials, Part III: Nanoscale technologies for assessing risk and improving public health. Toxicol. Sci. 88, 298-306.
2. Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K., Trottier, R., and Wood, S. (2006). Research strategies for safety evaluation of nanomaterials, part V: Role of dissolution in biological fate and effects of nanoscale particles. Toxicol. Sci. 90, 23-32.
3. Brunner, T. J., Wick, P., Manser, P., Spohn, P., Grass, R. N., Limbach, L. K., Bruininck, A., and Stark, W. J. (2006). In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40, 4374-4381.
4. Chang, J. S., Chang, K. L., Hwang, D. F., and Kong, Z. L. (2007). In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 41, 2064-2068.
5. Delsuc, M. A., and Malliavin, T. E. (1998). Maximum-entropy processing of dosy nmr-spectra. Anal. Chem. 70, 2146-2148.
6. Flick, D. A., and Gifford, G. E. (1984), Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol. Methods 68, 167-175.
7. Holsapple, M. P., Farland, W. H., Landry, T. D., Monteiro-Riviere, N. A., Carter, J. M., Walker, N. J., and Thomas, K. V. (2005). Research strategies for safety evaluation of nanomaterials, part II: Toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol. Sci. 88, 12-17.
8. Iler, R. K. (1979). In The Chemistry of Silica: Solubility, Polymerization, Colloid and Surface properties and Biochemistry. Wiley, New York.
9. Jin, Y., Kannan, S., Wu, M., and Zhao, J. X. (2007). Toxicity of luminescent silica nanoparticles to living cells. Chem. Res. Toxicol. 20, 1126-1133.
10. Lin, W., Huang, Y. W., Zhou, X. D., and Ma, Y. (2006). In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 217, 252-259.
11. Lison, D., and Lauwerys, R. (1990). In vitro cytotoxic effects of cobalt-containing dusts on mouse peritoneal and rat alveolar macrophages. Environ. Res. 52, 187-198.
12. Monteiller, C., Tran, L., MacNee, W., Faux, S., Jones, A., Miller, B., and Donaldson, K. (2007). The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: The role of surface area. Occup. Environ. Med. 64, 609-615.
13. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
14. Nel, A., Xia, T., Madler, L., and Li, N. (2006). Toxic potential of materials at the nanolevel. Science 311, 622-627.
15. Oberdorster, G., Oberdorster, E., and Oberdorster, J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839.
16. Oberdorster, G., Oberdorster, E., and Oberdorster, J. (2007). Concepts of nanoparticle dose metric and response metric. Environ. Health Perspect. 115, A290.
17. Powers, K. W., Brown, S. C., Krishna, V. B., Wasdo, S. C., Moudgil, B. M., and Roberts, S. M. (2006). Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90, 296-303.
18. Roesems, G., Hoet, P. H., Demedts, M., and Nemery, B. (1997). In vitro toxicity of cobalt and hard metal dust in rat and human type II pneumocytes. Pharmacol. Toxicol. 81, 74-80.
19. Suggs, J. E., Madden, M. C., Friedman, M., and Edgell, C. J. (1986). Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood 68, 925-929.
20. Teeguarden, J. G., Hinderliter, P. M., Orr, G., Thrall, B. D., and Pounds, J. G. (2007). Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95, 300-312.
21. Thomas, K., and Sayre, P. (2005). Research strategies for safety evaluation of nanomaterials, Part I: Evaluating the human health implications of exposure to nanoscale materials. Toxicol. Sci. 87, 316-321.
22. Thomas, T., Thomas, K., Sadrieh, N., Savage, N., Adair, P., and Bronaugh, R. (2006). Research strategies for safety evaluation of nanomaterials, part VII: Evaluating consumer exposure to nanoscale materials. Toxicol. Sci. 91, 14-19.
23. Tsuji, J. S., Maynard, A. D., Howard, P. C., James, J. T., Lam, C. W., Warheit, D. B., and Santamaria, A. B. (2006). Research strategies for safety evaluation of nanomaterials, part IV: Risk assessment of nanoparticles. Toxicol. Sci. 89, 42-50.
24. van-Blaaderen, A., and Kentgens, A. P. M. (2007). Particle morphology and chemical microstructure of colloidal silica spheres made from alkoxysilanes. J. No-Crystalline Solids 149, 149-161.
25. Warheit, D. B., Borm, P. J., Hennes, C., and Lademann, J. (2007). Testing strategies to establish the safety of nanomaterials: Conclusions of an ECETOC workshop. Inhal. Toxicol. 19, 631-643.
26. Wittmaack, K. (2007). In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: Particle number, surface area, or what? Environ. Health Perspect. 115, 187-194.
27. Wörle-Knirsch, J. M., Pulskamp, K., and Krug, H. F. (2006). Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6, 1261-1268.